Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus: the (NEOCRTEC5010) trial—a timely and welcome clinical trial from the Far East

Each year world-wide approximately 400,000 cancers of the esophagus are registered. Half of them are occurring in China being squamous cell cancer (SCC) in over 90% the patients. This is in contrast with the Western experience where adenocarcinoma is the predominant cancer type.